cp wire

CP Wire Articles

With a growing body of science linking gut microbiota to inflammatory bowel disease (IBD), a need exists in clinical settings to understand changes in the gut microbial community as they relate to... read more

Wed, 11/7/18 - 01:02 pm
  • The FDA also previously granted orphan drug designation for cannabidiol in the treatment of autoimmune hepatitis
  • Revive is developing cannabinoid pharmaceuticals to treat rare... read more
Wed, 11/7/18 - 09:23 am
  • In rodents with human prostate cancer, FOR46 eliminated the tumor and led to long-term survival
  • At this point, Fortis is focused on moving a single asset (FOR46) forward
... read more
Tue, 11/6/18 - 09:23 am
  • PTCL accounts for approximately 10 percent of non-Hodgkin lymphoma cases in the U.S. and Europe
  • It may account for as much as 24 percent in parts of Asia.

Seattle... read more

Mon, 11/5/18 - 10:08 am
  • More than 30 million people in the US and Europe suffer from food allergies
  • One in 13 U.S. children are at risk for life-threatening anaphylaxis
  • AllerGenis is creating the... read more
Mon, 11/5/18 - 09:53 am
  • Microbiome diversity returned 10 days after FMT administration
  • The therapy appeared to have an anti-imflammatory impact

AML standard intensive induction chemotherapy... read more

Fri, 11/2/18 - 09:34 am
  • Diagnostic errors result in an estimated 40,000 to 80,000 deaths per year
  • Three clinical categories – cardiovascular events, infections and cancers – are responsible for a... read more
Thu, 11/1/18 - 11:05 am
  • BAT8001 is also being studied gastric cancers
  • Bio-Thera recently announced that is BLA for a Humira biosimilar had been accepted for review in China
  • The company is also... read more
Thu, 11/1/18 - 09:52 am

Shavit Capital announced on 10/31/18 the completion of a $100 million funding round for its fifth fund. Founded and managed by Gary Leibler, Shavit Capital has over $400 million under management... read more

Wed, 10/31/18 - 11:31 am
  • Arrowhead will receive $175 million upfront
  • J&J will make a $75 million equity investment
  • Janssen receives a worldwide exclusive license to the ARO-HBV program
  • ... read more
Wed, 10/31/18 - 10:25 am
  • Tango will receive $50 million up front
  • The company could receive up to $1.7 billion in additional payments
  • The partnership will focus on building a pipeline of novel immuno... read more
Wed, 10/31/18 - 09:34 am
  • 1 in 1000 women over the age of 40 lives with PBC
  • The company also has clinical trials underway for NASH

CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced... read more

Tue, 10/30/18 - 10:23 am

Janssen Pharmaceutical today unveiled 96-week results from the pivotal Phase 3 AMBER study of Symtuza (darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide... read more

Tue, 10/30/18 - 09:53 am
  • Banyan BTI is the first test to aid in the diagnosis of concussion
  • The U.S. CDC estimates there are more than 2.5 million emergency room visits annually in the U.S. alone
... read more
Tue, 10/30/18 - 09:44 am
  • Larazotide is a tight junction regulator
  • The drug is also in Ph III trials for celiac disease
  • The FDA awarded fast track status to Larazotide for celiac
  • If approved... read more
Mon, 10/29/18 - 09:45 am
  • Framework may also help protect dementia patients
  • One researcher attributes Watson's failure in cancer diagnosis to a lack of emotion in the data

BPU Holdings... read more

Mon, 10/29/18 - 09:17 am
  • A dose-response relationship of increased gains in visual acuity (VA) was shown with ascending dose levels of OPT-302
  • OPT-302 is also being studied in wet AMD patients

... read more

Fri, 10/26/18 - 09:52 am

Galecto Biotech AB, the leading developer of galectin modulators for the treatment of severe diseases, including fibrosis and cancer, today announced the successful closing of a €79 million series... read more

Fri, 10/26/18 - 09:37 am
  • Enterome will receive an upfront payment of $50 million end is eligible to receive up to $640 in additional payments
  • Enterome and Takeda also have agreements targeting multiple other... read more
Thu, 10/25/18 - 12:41 pm


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.